Glioblastoma: open trials in Switzerland

22 open trials have a site in Switzerland. Registry data; only the trial team decides who can take part.

NCT06641908
Anti-GD2 ADC M3554 in Advanced Solid Tumors
Trial Treatment · Phase 1 · EMD Serono Research & Development Institute, Inc.
Universitaetsspital Zuerich - Klinik fuer Neurologie, Zurich
Registry updated 2026-11-05
NCT07366892
Leica Microsystems Sponsored PMCF Study to Collect and Confirm Clinical Data on the Performance of the GLOW400 Device When Used in Accordance With Its Intended Use
Research · Leica Microsystems (Schweiz) AG
University Hospital Basel, Basel
Registry updated 2026-11-03
NCT03970447
A Trial to Evaluate Multiple Regimens in Newly Diagnosed and Recurrent Glioblastoma
Trial Treatment · Phase 2/3 · Global Coalition for Adaptive Research
Centre Hospitalier Universitaire Vaudois Lausanne, Lausanne · University Hospital Zurich, Zurich
Registry updated 2026-11-02
NCT05765812
A Study of Zedoresertib (Debio 0123) in Combination With Temozolomide in Adult Participants With Recurrent or Progressive Glioblastoma and of Zedoresertib (Debio 0123) in Combination With Temozolomide and Radiotherapy in Adult Participants With Newly Diagnosed Glioblastoma
Trial Treatment · Phase 1/2 · Debiopharm International SA
Universitaetsspital Zuerich, Zurich
Registry updated 2026-10-28
NCT06804655
Pharmacoscopy for Patients With Refractory Primary Brain Tumors
Trial Treatment · Phase 2 · University of Zurich
University Hospital Basel, Basel · Cantonal Hospital St Gallen, Sankt Gallen · University Hospital Zurich, Zurich
Registry updated 2026-09-21
NCT07284628
Vortioxetine for Newly Diagnosed Glioblastoma
Trial Treatment · Phase 2 · University of Zurich
University Hospital Zurich, Zurich
Registry updated 2026-06-29
NCT04732065
ONC206 for Treatment of Newly Diagnosed, Recurrent Diffuse Midline Gliomas, and Other Recurrent Malignant CNS Tumors
Trial Treatment · Phase 1 · Sabine Mueller, MD, PhD
The University Children's Hospital in Zurich, Zurich
Registry updated 2026-06-11
NCT05904119
Lomustine With and Without Reirradiation for First Progression of Glioblastoma: a Randomized Phase III Study
Trial Treatment · Phase 3 · European Organisation for Research and Treatment of Cancer - EORTC
Oncology Institute of Southern Switzerland (IOSI) - Ospedale San Giovanni, Bellinzona · UniversitaetsSpital Zurich - Neurology Clinic, Zurich
Registry updated 2026-06-08
NCT07616986
LITT for Ultra-early GBM Recurrence
Trial Treatment · Insel Gruppe AG, University Hospital Bern
Dep. of Neurosurgery, Bern University Hospital, Bern
Registry updated 2026-06-01
NCT07263438
Efficacy of the Combination of Trimipramine and Atezolizumab With Bevacizumab in Patients With Recurrent Glioblastoma: a Phase 2 Trial
Trial Treatment · Phase 2 · Centre Hospitalier Universitaire Vaudois
Kantonsspital Aarau, Aarau · Universitätsspital Basel, Basel · Bern Inselspital, Bern · HFR Fribourg - Hôpital cantonal, Fribourg · Centre Hospitalier Universitaire Vaudois, Lausanne · Luzerner Kantonsspital, Lucerne · Universitätsspital Zürich, Zurich
Registry updated 2026-02-13
NCT02394626
Surgery for Recurrent Glioblastoma
Trial Treatment · Phase 2 · Insel Gruppe AG, University Hospital Bern
Universitätsspital Basel, Basel · Dep. of Neurosurgery, Bern University Hospital, Bern · Dep. of Neurosurgery, Centre hospitalier universitaire vaudois, Lausanne · Ospedale Regionale di Lugano, Lugano
Registry updated 2026-02-02
NCT07162324
A Multicenter, Prospective Study for Glioblastoma Patients
Research · Larissa University Hospital
Inselspital University Hospital of Bern, Bern
Registry updated 2025-09-09
NCT04266977
Restrictive Use of Dexamethasone in Glioblastoma
Trial Treatment · Insel Gruppe AG, University Hospital Bern
Universitätsspital Basel, Basel · Department of Neurosurgery, Bern · Kantonsspital St. Gallen, Sankt Gallen · Universitätsspital Zürich, Zurich
Registry updated 2025-07-09
NCT05565326
Response Assessment During MR-guided Radiation Therapy for Glioblastoma
Research · University of Zurich
University Hospital Zurich, Zurich
Registry updated 2025-03-03
NCT05911230
Advanced Diffusion MRI to Differentiate Tumor Recurrence From Pseudoprogression in Patients With Glioblastoma and Brain Metastases
Trial Treatment · University Hospital, Basel, Switzerland
University Hospital Basel, Basel
Registry updated 2025-01-29
NCT05664464
Glutamate Inhibitors in Glioblastoma
Trial Treatment · Phase 1/2 · University of Zurich
University Hospital Zurich, Zurich
Registry updated 2024-05-10
NCT06283927
The RECSUR-study: Resection Versus Best Oncological Treatment for Recurrent Glioblastoma (ENCRAM 2302)
Research · Jasper Gerritsen
Inselspital Universitätsspital Bern, Bern
Registry updated 2024-02-28
NCT06118723
The SUPRAMAX Study: Supramaximal Resection Versus Maximal Resection for High-Grade Glioma Patients (ENCRAM 2201)
Research · Jasper Gerritsen
Inselspital Universitätsspital Bern, Bern
Registry updated 2024-02-22
NCT06273176
The RECMAP-study: Resection With or Without Intraoperative Mapping for Recurrent Glioblastoma
Research · Erasmus Medical Center
Inselspital Universitätsspital Bern, Bern
Registry updated 2024-02-22
NCT06146725
The RESBIOP-study: Resection Versus Biopsy in High-grade Glioma Patients (ENCRAM 2202)
Research · Jasper Gerritsen
Inselspital Universitätsspital Bern, Bern
Registry updated 2023-11-27
NCT06146738
The PALSUR-study: Palliative Care Versus Surgery in High-grade Glioma Patients (ENCRAM 2203)
Research · Jasper Gerritsen
Inselspital Universitätsspital Bern, Bern
Registry updated 2023-11-27
NCT04443010
Safety and Efficacy of L19TNF Plus Temozolomide Chemoradiotherapy in Patients With Newly Diagnosed Glioblastoma
Trial Treatment · Phase 1/2 · Philogen S.p.A.
UniversitatSpital USZ, Zurich
Registry updated 2023-10-10

All Glioblastoma trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error